Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,316.60 -70.96 -0.46%
S&P 500 1,657.85 -11.31 -0.68%
Nasdaq 3,459.93 -42.20 -1.20%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%

French Cyclkist Houanard Gets Two-Year Ban for EPO Use

French cyclist Steve Houanard has been suspended for two years after testing positive for the banned substance Erythropoietin, or EPO, the International Cycling Union said.

The 26-year-old Ag2r-La Mondiale rider tested positive for the endurance-boosting drug during an out-of-competition test in September, the UCI said in an e-mailed statement today. Houanard has accepted his suspension, it said.

The UCI further said it has asked the Belgian National Cycling Federation RLVB to start a “disciplinary procedure” against rider Leif Hoste for a violation of anti-doping rules on the basis of his blood profile in his biological passport.

To contact the reporter on this story: Danielle Rossingh in London at drossingh@bloomberg.net.

To contact the editor responsible for this story: Christopher Elser at celser@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link